More from
Key Takeaways: Zerlasiran, a short interfering RNA (siRNA) targeting lipoprotein(a) (Lp(a)), was well tolerated and… Continue Reading
Key Takeaways: The AMULET IDE trial compared the AMPLATZER Amulet occluder with the Watchman 2.5… Continue Reading
Key Takeaways: In this international registry, 266 patients with dual pathology, aortic stenosis and cardiac… Continue Reading
Leave a Reply
You must be logged in to post a comment.